Second trimester amniotic fluid bisphenol A concentration is associated with decreased birth weight in term infants

Reproductive Toxicology

Volumn 67, Issue , 2017, Pages 1-9

  Pinney, Sara E ^a,b   Mesaros, Clementina A ^b   Snyder, Nathaniel W ^b,c   Busch, Christine M ^b   Xiao, Rui ^b   Aijaz, Sara ^a   Ijaz, Naila ^a   Blair, Ian A ^b   Manson, Jeanne M ^d  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c DREXEL UNIVERSITY   (United States)

^d Drexel University ^*  (United States)

Author keywords

Bisphenol A; Developmental origins of health and disease; In utero exposure

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; BENZHYDRYL DERIVATIVE; ENDOCRINE DISRUPTOR; PHENOL DERIVATIVE;

ADOLESCENT; ADULT; AMNION FLUID LEVEL; ARTICLE; CONTROLLED STUDY; ELECTRON CAPTURE ATMOSPHERIC PRESSURE CHEMICAL IONIZATION TANDEM MASS SPECTROMETRY; FEMALE; FETUS; HUMAN; INFANT; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; LOW BIRTH WEIGHT; MALE; MASS SPECTROMETRY; PRENATAL EXPOSURE; SECOND TRIMESTER PREGNANCY; AMNION FLUID; CHEMISTRY; ETIOLOGY; PATHOPHYSIOLOGY; PREGNANCY; TANDEM MASS SPECTROMETRY;

AMNIOTIC FLUID; BENZHYDRYL COMPOUNDS; CHROMATOGRAPHY, LIQUID; ENDOCRINE DISRUPTORS; FEMALE; HUMANS; INFANT, LOW BIRTH WEIGHT; LIMIT OF DETECTION; PHENOLS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRENATAL EXPOSURE DELAYED EFFECTS; TANDEM MASS SPECTROMETRY;

EID: 84995436833     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2016.11.007     Document Type: Article

References (56)

1. [1] Crews, D., McLachlan, J.A., Epigenetics, evolution, endocrine disruption, health, and disease. Endocrinology 147 (2006), S4–10.
2. [2] Crain, D.A., Janssen, S.J., Edwards, T.M., Heindel, J., Ho, S.M., Hunt, P., et al. Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing. Fertil. Steril. 90 (2008), 911–940.
3. [3] Lang, I.A., Galloway, T.S., Scarlett, A., Henley, W.E., Depledge, M., Wallace, R.B., et al. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 300 (2008), 1303–1310.
4. [4] Ranjit, N., Siefert, K., Padmanabhan, V., Bisphenol-A and disparities in birth outcomes: a review and directions for future research. J. Perinatol. 30 (2010), 2–9.
5. [5] Mikolajewska, K., Stragierowicz, J., Gromadzinska, J., Bisphenol, A., - Application, sources of exposure and potential risks in infants, children and pregnant women. Int. J. Occup. Med. Environ. Health 28 (2015), 209–241.
6. [6] Seachrist, D.D., Bonk, K.W., Ho, S.M., Prins, G.S., Soto, A.M., Keri, R.A., A review of the carcinogenic potential of bisphenol a. Reprod. Toxicol. 59 (2015), 167–182.
7. [7] Alonso-Magdalena, P., Ropero, A.B., Soriano, S., Garcia-Arevalo, M., Ripoll, C., Fuentes, E., et al. Bisphenol-A acts as a potent estrogen via non-classical estrogen triggered pathways. Mol. Cell. Endocrinol. 355 (2012), 201–207.
8. [8] Hotchkiss, A.K., Rider, C.V., Blystone, C.R., Wilson, V.S., Hartig, P.C., Ankley, G.T., et al. Fifteen years after Wingspread?environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go. Toxicol. Sci. 105 (2008), 235–259.
9. [9] Howdeshell, K.L., Hotchkiss, A.K., Thayer, K.A., Vandenbergh, J.G., vom Saal, F.S., Exposure to bisphenol A advances puberty. Nature 401 (1999), 763–764.
10. [10] Rubin, B.S., Soto, A.M., Bisphenol, A., Perinatal exposure and body weight. Mol. Cell. Endocrinol. 304 (2009), 55–62.
11. [11] Savabieasfahani, M., Kannan, K., Astapova, O., Evans, N.P., Padmanabhan, V., Developmental programming: differential effects of prenatal exposure to bisphenol-A or methoxychlor on reproductive function. Endocrinology 147 (2006), 5956–5966.
12. [12] Susiarjo, M., Xin, F., Bansal, A., Stefaniak, M., Li, C., Simmons, R.A., et al. Bisphenol an exposure disrupts metabolic health across multiple generations in the mouse. Endocrinology 156 (2015), 2049–2058.
13. [13] Kim, J.C., Shin, H.C., Cha, S.W., Koh, W.S., Chung, M.K., Han, S.S., Evaluation of developmental toxicity in rats exposed to the environmental estrogen bisphenol A during pregnancy. Life Sci. 69 (2001), 2611–2625.
14. [14] Rubin, B.S., Murray, M.K., Damassa, D.A., King, J.C., Soto, A.M., Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environ. Health Perspect. 109 (2001), 675–680.
15. [15] Ryan, K.K., Haller, A.M., Sorrell, J.E., Woods, S.C., Jandacek, R.J., Seeley, R.J., Perinatal exposure to bisphenol-a and the development of metabolic syndrome in CD-1 mice. Endocrinology 151 (2010), 2603–2612.
16. [16] Philippat, C., Mortamais, M., Chevrier, C., Petit, C., Calafat, A.M., Ye, X., et al. Exposure to phthalates and phenols during pregnancy and offspring size at birth. Environ. Health Perspect. 120 (2012), 464–470.
17. [17] Wolff, M.S., Engel, S.M., Berkowitz, G.S., Ye, X., Silva, M.J., Zhu, C., et al. Prenatal phenol and phthalate exposures and birth outcomes. Environ. Health Perspect. 116 (2008), 1092–1097.
18. [18] Calafat, A.M., Longnecker, M.P., Koch, H.M., Swan, S.H., Hauser, R., Goldman, L.R., et al. Optimal exposure biomarkers for nonpersistent chemicals in environmental epidemiology. Environ. Health Perspect. 123 (2015), A166–A168.
19. [19] Susiarjo, M., Hassold, T.J., Freeman, E., Hunt, P.A., Bisphenol, A., exposure in utero disrupts early oogenesis in the mouse. PLoS Genet., 3, 2007, e5.
20. [20] Barker, D.J., Hales, C.N., Fall, C.H., Osmond, C., Phipps, K., Clark, P.M., Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 36 (1993), 62–67.
21. [21] Troisi, J., Mikelson, C., Richards, S., Symes, S., Adair, D., Zullo, F., et al. Placental concentrations of bisphenol A and birth weight from births in the Southeastern U.S. Placenta 35 (2014), 947–952.
22. [22] Ye, X., Wong, L.Y., Bishop, A.M., Calafat, A.M., Variability of urinary concentrations of bisphenol A in spot samples, first morning voids, and 24-hour collections. Environ. Health Perspect. 119 (2011), 983–988.
23. [23] Barr, D.B., Bishop, A., Needham, L.L., Concentrations of xenobiotic chemicals in the maternal-fetal unit. Reprod. Toxicol. 23 (2007), 260–266.
24. [24] Park, B.Y., Lee, B.K., Use of meconium in perinatal epidemiology: potential benefits and pitfalls. Ann. Epidemiol. 24 (2014), 878–881.
25. [25] Gyllenhammar, I., Troger, R., Glynn, A., Rosen, J., Hellenas, K.E., Lignell, S., Serum levels of unconjugated bisphenol A are below 0.2 ng/ml in Swedish nursing women when contamination is minimized. Environ. Int. 64 (2014), 56–60.
26. [26] Vandenberg, L.N., Gerona, R.R., Kannan, K., Taylor, J.A., van Breemen, R.B., Dickenson, C.A., et al. A round robin approach to the analysis of bisphenol A (BPA) in human blood samples. Environ. Health, 13, 2014, 25.
27. [27] Thayer, K.A., Doerge, D.R., Hunt, D., Schurman, S.H., Twaddle, N.C., Churchwell, M.I., et al. Pharmacokinetics of bisphenol A in humans following a single oral administration. Environ. Int. 83 (2015), 107–115.
28. [28] Heavner, K., Burstyn, I., A simulation study of categorizing continuous exposure variables measured with error in autism research: small changes with large effects. Int. J. Environ. Res. Public Health 12 (2015), 10198–10234.
29. [29] Liu, Z., Wolff, M.S., Moline, J., Analysis of environmental biomarkers in urine using an electrochemical detector. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 819 (2005), 155–159.
30. [30] Hornung, R.W., Reed, L.D., Estimation of average concentration in the presence of nondetectable values. Appl. Occup. Environ. Hyg. 5 (1990), 46–51.
31. [31] Bloom, M.S., Buck Louis, G.M., Sundaram, R., Maisog, J.M., Steuerwald, A.J., Parsons, P.J., Birth outcomes and background exposures to select elements, the Longitudinal Investigation of Fertility and the Environment (LIFE). Environ. Res. 138 (2015), 118–129.
32. [32] Harville, E.W., Madkour, A.S., Xie, Y., Predictors of birth weight and gestational age among adolescents. Am. J. Epidemiol. 176:Suppl. 7 (2012), S150–63.
33. [33] Edlow, A.G., Chen, M., Smith, N.A., Lu, C., McElrath, T.F., Fetal bisphenol A exposure: concentration of conjugated and unconjugated bisphenol A in amniotic fluid in the second and third trimesters. Reprod. Toxicol. 34 (2012), 1–7.
34. [34] Engel, S.M., Levy, B., Liu, Z., Kaplan, D., Wolff, M.S., Xenobiotic phenols in early pregnancy amniotic fluid. Reprod. Toxicol. 21 (2006), 110–112.
35. [35] Ikezuki, Y., Tsutsumi, O., Takai, Y., Kamei, Y., Taketani, Y., Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Hum. Reprod. 17 (2002), 2839–2841.
36. [36] Yamada, H., Furuta, I., Kato, E.H., Kataoka, S., Usuki, Y., Kobashi, G., et al. Maternal serum and amniotic fluid bisphenol A concentrations in the early second trimester. Reprod. Toxicol. 16 (2002), 735–739.
37. [37] Dekant, W., Volkel, W., Human exposure to bisphenol A by biomonitoring: methods, results and assessment of environmental exposures. Toxicol. Appl. Pharmacol. 228 (2008), 114–134.
38. [38] Hines, E.P., Mendola, P., von Ehrenstein, O.S., Ye, X., Calafat, A.M., Fenton, S.E., Concentrations of environmental phenols and parabens in milk, urine and serum of lactating North Carolina women. Reprod. Toxicol. 54 (2015), 120–128.
39. [39] Lee, B.E., Park, H., Hong, Y.C., Ha, M., Kim, Y., Chang, N., et al. Prenatal bisphenol a and birth outcomes: MOCEH (Mothers and children's environmental health) study. Int. J. Hyg. Environ. Health 217 (2014), 328–334.
40. [40] Nahar, M.S., Liao, C., Kannan, K., Harris, C., Dolinoy, D.C., In utero bisphenol A concentration, metabolism, and global DNA methylation across matched placenta, kidney, and liver in the human fetus. Chemosphere 124 (2015), 54–60.
41. [41] Wolff, M.S., Teitelbaum, S.L., Pinney, S.M., Windham, G., Liao, L., Biro, F., et al. Investigation of relationships between urinary biomarkers of phytoestrogens, phthalates, and phenols and pubertal stages in girls. Environ. Health Perspect. 118 (2010), 1039–1046.
42. [42] Nishikawa, M., Iwano, H., Yanagisawa, R., Koike, N., Inoue, H., Yokota, H., Placental transfer of conjugated bisphenol A and subsequent reactivation in the rat fetus. Environ. Health Perspect. 118 (2010), 1196–1203.
43. [43] Suzuki, A., Sugihara, A., Uchida, K., Sato, T., Ohta, Y., Katsu, Y., et al. Developmental effects of perinatal exposure to bisphenol-A and diethylstilbestrol on reproductive organs in female mice. Reprod. Toxicol. 16 (2002), 107–116.
44. [44] Takahashi, O., Oishi, S., Disposition of orally administered 2,2-Bis(4-hydroxyphenyl)propane (Bisphenol A) in pregnant rats and the placental transfer to fetuses. Environ. Health Perspect. 108 (2000), 931–935.
45. [45] Schonfelder, G., Wittfoht, W., Hopp, H., Talsness, C.E., Paul, M., Chahoud, I., Parent bisphenol A accumulation in the human maternal-fetal-placental unit. Environ. Health Perspect. 110 (2002), A703–7.
46. [46] Padmanabhan, V., Siefert, K., Ransom, S., Johnson, T., Pinkerton, J., Anderson, L., et al. Maternal bisphenol-A levels at delivery: a looming problem. J. Perinatol. 28 (2008), 258–263.
47. [47] Weinberger, B., Vetrano, A.M., Archer, F.E., Marcella, S.W., Buckley, B., Wartenberg, D., et al. Effects of maternal exposure to phthalates and bisphenol A during pregnancy on gestational age. J. Matern. Fetal Neona 27 (2014), 323–327.
48. [48] Cantonwine, D.E., Ferguson, K.K., Mukherjee, B., McElrath, T.F., Meeker, J.D., Urinary bisphenol a levels during pregnancy and risk of preterm birth. Environ. Health Perspect. 123 (2015), 895–901.
49. [49] Vandenberg, L.N., Maffini, M.V., Sonnenschein, C., Rubin, B.S., Soto, A.M., Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr. Rev. 30 (2009), 75–95.
50. [50] Hugo, E.R., Brandebourg, T.D., Woo, J.G., Loftus, J., Alexander, J.W., Bisphenol, Ben-Jonathan N., A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ. Health Perspect. 116 (2008), 1642–1647.
51. [51] Vandenberg, L.N., Colborn, T., Hayes, T.B., Heindel, J.J., Jacobs, D.R. Jr., Lee, D.H., et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr. Rev. 33 (2012), 378–455.
52. [52] Li, Y., Ley, S.H., Tobias, D.K., Chiuve, S.E., VanderWeele, T.J., Rich-Edwards, J.W., et al. Birth weight and later life adherence to unhealthy lifestyles in predicting type 2 diabetes: prospective cohort study. BMJ, 351, 2015, h3672.
53. [53] Whincup, P.H., Kaye, S.J., Owen, C.G., Huxley, R., Cook, D.G., Anazawa, S., et al. Birth weight and risk of type 2 diabetes: a systematic review. JAMA 300 (2008), 2886–2897.
54. [54] Teitelbaum, S.L., Britton, J.A., Calafat, A.M., Ye, X., Silva, M.J., Reidy, J.A., et al. Temporal variability in urinary concentrations of phthalate metabolites, phytoestrogens and phenols among minority children in the United States. Environ. Res. 106 (2008), 257–269.
55. [55] Ginsberg, G., Rice, D.C., Does rapid metabolism ensure negligible risk from bisphenol A. Environ. Health Perspect. 117 (2009), 1639–1643.
56. [56] Lucier, G.W., Sonawane, B.R., McDaniel, O.S., Glucuronidation and deglucuronidation reactions in hepatic and extrahepatic tissues during perinatal development. Drug Metab. Dispos. 5 (1977), 279–287.